$AIP

Bayview Legacy, LLC sold $7.0M of AIP (indirect holdings)

Bayview Legacy, LLC sold 192,686 indirectly-held shares of Arteris, Inc. (AIP) at an average of $36.32 ($34.77–$43.24, $7.00M total) across 8 trades on 2026-07-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bayview Legacy, LLC
Published Jul 6, 2026, 9:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 6, 2026, 9:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The disclosed ~$7.0M sale can influence short-term sentiment, but the 10b5-1 designation generally lowers the probability of immediate fundamental repricing.

02

Market read

Primary-source insider sale disclosure for AIP with execution details and post-transaction share count.

03

What to watch

The filing does not disclose intent beyond the plan; traders should compare with prior insider activity and whether additional scheduled tranches remain.

Relevance 5/10Novelty 5/10Timing: Filed 2026-07-06 for a sale executed 2026-07-02 (after-hours/next-session positioning).

Background

SEC Form 4 reports insider transactions; this one is an open-market sale by a 10% owner via an indirect holding structure.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Bayview Legacy, LLC (10% owner) filed a Form 4 showing an open-market sale of 192,686 AIP shares for ~$7.0M on 2026-07-02.

Expected impact

Likely limited/short-lived impact; watch for follow-through selling signals versus stabilization after the disclosed tranche.

Evidence & confidence

The filing is primary-source and time-stamped, but the transaction is explicitly under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight.

Market effects

No sector read-through; this is a single-issuer insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Arteris, Inc.

    Subject of the Form 4; ticker AIP.

  • Bayview Legacy, LLC

    10% owner reporting an indirect open-market sale under a pre-arranged 10b5-1 plan.

Related articles

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn